SPECTRE is offering this webinar as a means to discuss practical considerations for health care institutions and partners when presented with a patient suspected of having a special pathogen. We will use example "paper patients "to walk through the steps necessary to provide appropriate care while maintaining public health and healthcare worker safety.

New article published in Open Forum of Infectious Diseases co-authored by SPECTRE’s Dr. Corri Levine: Appropriate representation is vital when conducting clinical trials and this is just as important during emerging infectious disease outbreaks. The Adaptive COVID-19 Treatment Trial (ACTT) was one of the first trials to test therapeutics against COVID-19, initiated early in the pandemic when very little was known about the disease and susceptible populations. This paper used ACTT as a model for selecting appropriate comparators when evaluating trial representation.

SPPH Symposium Student Poster

New article published in Open Forum of Infectious Diseases co-authored by SPECTRE’s Dr. Corri Levine: “Baricitinib treatment of COVID-19 is associated with a reduction of secondary infections.” A secondary analysis of patients enrolled in the ACTT-2 randomized controlled trial found that COVID-19 patients treated with remdesivir plus baricitinib were less likely to have a secondary infection during their care compared to those treated with remdesivir alone. This is a novel benefit for use of baricitinib and supports the safety of this therapeutic for use in COVID-19 patients.

On the #NETEC Situation Report for April 14, 2023, Dr. Corri Levine, a NETEC expert and virologist at The University of Texas Medical Branch shares three things you should know about avian influenza.

Resources developed by: Dr. Corri Levine